These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28208898)

  • 1. To Study the Efficacy of Difluprednate Ophthalmic Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative Inflammation in Cataract Surgery.
    Garg P; Tuteja N; Qayum S
    J Clin Diagn Res; 2016 Dec; 10(12):NC05-NC08. PubMed ID: 28208898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Efficacy of Difluprednate 0.05% Versus Prednisolone Acetate 1% in Controlling Inflammation and Macular Oedema Following Phacoemulsification: An Optical Coherence Tomography-Based Study.
    Panda BB; Nanda A; Swain SC
    Cureus; 2021 Apr; 13(4):e14673. PubMed ID: 34055520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study.
    Wilson ME; O'Halloran H; VanderVeen D; Roarty J; Plager DA; Markwardt K; Gedif K; Lambert SR
    Eye (Lond); 2016 Sep; 30(9):1187-94. PubMed ID: 27367745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized controlled fellow eye trial of pulse-dosed difluprednate 0.05% versus prednisolone acetate 1% in cataract surgery.
    Donnenfeld ED; Holland EJ; Solomon KD; Fiore J; Gobbo A; Prince J; Sandoval HP; Shull ER; Perry HD
    Am J Ophthalmol; 2011 Oct; 152(4):609-617.e1. PubMed ID: 21704965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difluprednate versus Prednisolone Acetate after Cataract Surgery: a Systematic Review and Meta-Analysis.
    KhalafAllah MT; Basiony A; Salama A
    BMJ Open; 2019 Nov; 9(11):e026752. PubMed ID: 31678934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery.
    Abessi B; Brooksby L; Schultze RL
    Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis.
    Foster CS; Davanzo R; Flynn TE; McLeod K; Vogel R; Crockett RS
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):475-83. PubMed ID: 20809807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difluprednate ophthalmic emulsion 0.05% (Durezol) administered two times daily for managing ocular inflammation and pain following cataract surgery.
    Smith S; Lorenz D; Peace J; McLeod K; Crockett RS; Vogel R
    Clin Ophthalmol; 2010 Sep; 4():983-91. PubMed ID: 20856594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of rimexolone 1% versus prednisolone acetate 1% in the control of postoperative inflammation following phacoemulsification cataract surgery.
    Yaylali V; Ozbay D; Tatlipinar S; Yildirim C; Ozden S
    Int Ophthalmol; 2004 Jan; 25(1):65-8. PubMed ID: 15085979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertension.
    Tijunelis MA; Person E; Niziol LM; Musch DC; Ernest P; McBain M; Mian SI
    J Cataract Refract Surg; 2017 Feb; 43(2):223-227. PubMed ID: 28366370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day for cataract postsurgical inflammation treatment: noninferiority trial.
    Valvecchia G; Kaufer R; Ferroni C; Zaldívar R; Masseroni M; Idiart C; Ferroni V; Marino F; Nuñez M; Del Papa M; Passerini MS
    J Cataract Refract Surg; 2022 Jul; 48(7):753-758. PubMed ID: 34759176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery.
    Struck HG; Bariszlovich A
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):737-42. PubMed ID: 11760033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
    Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G
    Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery.
    Simone JN; Pendelton RA; Jenkins JE
    J Cataract Refract Surg; 1999 May; 25(5):699-704. PubMed ID: 10330648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%.
    Stringer W; Bryant R
    Clin Ophthalmol; 2010 Oct; 4():1119-24. PubMed ID: 20957058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery.
    Kavuncu S; Horoz H; Ardagil A; Erbil HH
    Int Ophthalmol; 2008 Aug; 28(4):281-5. PubMed ID: 17762913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular pressure elevation from topical difluprednate use.
    Meehan K; Vollmer L; Sowka J
    Optometry; 2010 Dec; 81(12):658-62. PubMed ID: 21111374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial.
    Palacio-Pastrana C; Chávez-Mondragón E; Soto-Gómez A; Suárez-Velasco R; Montes-Salcedo M; Fernández de Ortega L; Nasser-Nasser L; Baiza-Durán L; Olvera-Montaño O; Muñoz-Villegas P
    Clin Ophthalmol; 2020; 14():1581-1589. PubMed ID: 32606573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.